New Review of Cost Effectiveness of Bundled Payments published by healthcare analyst Dr. William Matzner

Website of Dr William Matzner California

Website of Dr William Matzner California

Dr William L Matzner, medical doctor in California

Dr William L Matzner, medical doctor in California

Dr William L Matzner, Physician, California

Dr William L Matzner, Physician, California

Medical doctor and analyst Dr William L Matzner, California

Medical doctor and analyst Dr William L Matzner, California

Dr William Matzner, Physician and Researcher, California

Dr William Matzner, Physician and Researcher, California

The cost of healthcare is a much-discussed and ongoing issue. The new article by William L. Matzner, MD reviews “Bundled Payment for Care Improvement Advanced”

Healthcare Analytics, LLC (N/A:N/A)

If your objective is to provide the best decision-making for your organization and take a global view of your business, Cost Effectiveness Analysis can make your organization more competitive”

— Dr. William Matzner, California (Healthcare Analytics, LLC)

PALO ALTO, CALIFORNIA, UNITED STATES, March 23, 2019 /EINPresswire.com/ — The cost of healthcare continues to be a topic of intense discussion from kitchen tables, to board rooms, and finally to congressional hearings. Spurred by these conversations and allegations, insurance companies and entities such as Medicare and Medicaid have striven to conceive alternate payment approaches besides the traditional fee for service methods on the basis of reducing costs. Dr. William Matzner has published an overview article on this issue. The complete article will be published on the Blog of Dr. Matzner at https://drwilliammatzner.blogspot.com

Capitation (a system in which providers are given a defined sum per patient regardless of how many services are rendered in a defined period of time) has been around for many years and has been fraught with complaints among providers for inconsistencies between responsibility for and authority over patient interactions. The HMO model has also been attempted in various iterations with its focus on preventive care, but most have not survived, Kaiser Permanente being an exception. Medicare has since developed a method falling between that of full capitation and fee for service—the use of bundled payments or put more descriptively, episode-based payments. In this method, reimbursement of healthcare providers (both hospitals and physicians) is based on the expected costs for clinically defined episodes of care. Since 1984, bundling payment methods have been tried and as of 2012 almost one third of medical reimbursement is now from a bundling system.

In 2018, Medicare introduced a variation called Bundled Payment for Care Improvement Advanced (BPCI Advanced). In this model there are 48 episodes, 45 inpatient and three outpatient. Again there are four payment models, with model two being the most common. Several of the medical episodes included in BPCI Advanced include CHF, COPD, Sepsis, Acute MI and Pneumonia. As every physician would know, there is a wide variation in the degree of illness and the course of therapy within these diagnoses, and there is nothing uniform about each case.

For example, Sepsis includes three DRGs which range from uncomplicated to septic shock. Unlike elective surgery, providers cannot screen these patients to avoid complications, and in fact many of these patients develop complications and/or have significant comorbidities. All of these variables create significant variations of length in stay (LOS) and other costs associated with each hospitalization. In these cases, where there is a wide variation in costs, a need exists to employ a method to better predict these costs.

That methods exists but seems too seldom used. It is decision tree modeling that offers both the flexibility and complexity of interaction to more accurately predict costs than just a linear model which is commonly used. Since diseases such as sepsis, COPD and CHF can become a complex affair with many possible outcomes that would affect costs, this type of modeling lends itself to such an analysis. Armed with better predictability results, providers are better able to defend both real costs and to negotiate for more fairly applied payment schemes.

If your objective is to provide the best decision-making for your organization and take a global view of your business, expanding your sights beyond ROI, and educating other decision-makers, Cost Effectiveness Analysis can make your organization more competitive and more profitable.

William Lee Matzner, MD. is a recognized expert in Healthcare and Neuro Economics. With a Ph.D. in Economics, MBA and Medical Doctor degree, Dr. William L. Matzner will provide you with expert analysis on health and wellness programming, populations health management, disease management, new program development, facility development, equipment acquisitions, and other healthcare programs, acquisitions and initiatives. For more information about cost effectiveness analysis and improved financial accountability for your organization, visit Dr. Matzner at http://healthcareanalytics.biz. Dr. Matzner is also available for speaking engagements, retreat presentations and topic specific addresses.

Website: https://drwilliammatzner.com
Consulting Website: https://healthcareanalytics.biz
LinkedIn: https://www.linkedin.com/in/william-matzner-md-phd-mba-60219730
Blog: https://drwilliammatzner.blogspot.com
News: https://hype.news/dr-william-matzner/
News: https://hippocratesguild.com/dr-william-matzner
News: https://medicogazette.com/dr-william-matzner

Dr. William Matzner
Healthcare Analytics, LLC
+1 818-648-3551
email us here
Visit us on social media:
LinkedIn

Doctors Explain Why U.S. Healthcare Is So Expensive (HBO). VICE News visited a bunch of doctors in an attempt to make sense of our health care costs.


Source: EIN Presswire

No Indication of Elevated Blood Lead Levels Due to Sandy, Utah Water Incident Test Results Reveal

Intermountain Healthcare provided over 700 potentially affected residents with no-cost blood lead screening

We are always grateful for the opportunity to serve our community through collaboration with our public health colleagues to enhance community health.”

— Mikelle Moore, Intermountain senior vice president of community health

SANDY, UTAH, USA, March 22, 2019 /EINPresswire.com/ — Good news for Sandy City, Utah residents affected by the city’s recent water contamination issue.

Results are back from the free blood lead level screening tests provided by Intermountain Healthcare to 704 residents living in the affected areas – zones 1, 2, and 3. They show only one person tested above the 5.0μg/dL reference level at which the CDC recommends public health actions be initiated.

This is fewer than Salt Lake County Health Department (SLCoHD) would statistically expect for a population this size, based on the expected prevalence of elevated blood lead levels countywide.

“The one individual who tested above the CDC action level is an adult over the age of 65 with other possible exposures to lead; their blood lead level was 5.1 μg/dL,” said Gary Edwards, SLCoHD executive director.

Based on reports from Sandy City regarding the length of time that fluoride, lead, and copper were present in the water system, health officials had said the water situation was unlikely to have long-term health impacts for potentially affected residents. SLCoHD partnered with Intermountain Healthcare for the free lead testing to provide peace of mind for residents.

“We extend our thanks to Intermountain Healthcare for providing this service to these residents,” said Edwards. “We are grateful that these results confirm for those screened that any potential exposure to elevated levels of lead in this incident was indeed brief enough to not cause elevated blood lead levels.”

“We are always grateful for the opportunity to serve our community through collaboration with our public health colleagues to enhance community health,” said Mikelle Moore, senior vice president of community health for Intermountain.

Because lead is prevalent throughout the environment, SLCoHD recommends pregnant women and all children under six years of age countywide—regardless of involvement in the Sandy water incident—receive a blood lead test from their health care provider.

The most common source of lead poisoning in children is from old paint in homes built before 1978, but lead is also present in many other common products, including jewelry, tableware, charms, ammunition, fishing sinkers, stained glass, miniblinds, roofing, artificial turf, and even toys produced in countries without strict safety guidelines.

Intermountain Healthcare is a Utah-based not-for-profit system of 23 hospitals, 170 clinics, a Medical Group with some 2,300 employed physicians and advanced care practitioners, a health insurance company called SelectHealth, and other health services. Intermountain is widely recognized as a leader in transforming healthcare through evidence-based best practices, high quality, and sustainable costs. For more information about Intermountain, visit intermountainhealthcare.org.

Jess Gomez
Intermountain Healthcare
801-718-8495
email us here


Source: EIN Presswire

Universal Solar Technology, Inc. and Safe Bank Join Forces

Innovative companies together to deliver next level support functionality to cannabis sector.

Universal Solar Technology, Inc. (OTCMKTS:UNSS)

HOUSTON, TEXAS, UNITED STATES, March 22, 2019 /EINPresswire.com/ — In a move that will expand its business plan and industry focus, Universal Solar Technology, Inc. (OTC Markets Pink: UNSS), has signed a Letter of Intent with the emerging online international banking firm Safe Bank, with headquarters in London, U.K./South Africa. The extensive plans of the partnership include banking and financial services products which will prove to be disruptive to some of the current traditional banking and financial services product offerings. However, the initial focus of the partnership will be the release of a crypto currency coin targeting the cannabis industry. The coin is labeled "Khrysos" after the Greek god of gold.

Safe Bank President and CEO, Marckensie Theresias says, “We believe that the fledgling cannabis industry is ripe to demonstrate the true abilities of fintech combined with blockchain technology. The ability to track every step of a transaction and attach the data to each currency unit will reduce the stress placed on all network participants including government agencies. This tracking capability will address the need for access to information that satisfies governmental and legal regulatory requirements. We are convinced that partnering with Universal Solar Technology will open doors to an enhanced strategy deployment approach available through the public markets and allow Safe Bank to fully develop this solution.”

Darrell A. Calloway, President of Universal Solar Technology, Inc. says of the budding partnership, “Universal Solar has been careful in its selection of the right opportunity to expand its industry reach. We were looking for an opportunity that had the right product and company personality. We believe Safe Bank brings an awesome opportunity in the banking industry and are convinced that its leadership has the personality that compliments the core values of Universal Solar.”

The release of Khrysos is planned for second quarter 2019.

Paul D. Landrew
Universal Solar Technology, Inc.
+1 832-229-7046
email us here


Source: EIN Presswire

Intermountain Caregivers Pioneer Mental Health Support Group for Emergency Staff After Losing One of Their Own

The OASIS program will train nurses and physicians in suicide prevention and will select leaders and peer counselors

We know people are silently struggling with issues both in and out of work, and we want them to know they don’t have to.”

— Adam Balls, MD, chair of the ED at Intermountain Medical Center

SALT LAKE CITY, UTAH, USA, March 22, 2019 /EINPresswire.com/ — Doctors, nurses, and caregivers in the Emergency Department at Intermountain Medical Center have created a new mental health peer support system. The OASIS program aims to confront post-traumatic stress disorder type symptoms and other mental trauma caregivers can experience at work. OASIS stands for:

Outreach education
Administrative support
Staff support
Internal/Incident support
Social support for all members of our ED family

Adam Balls, MD, chair of the Emergency Department at Intermountain Medical Center, Gary Brunson, RN, assistant nurse manager, and several colleagues developed the OASIS program after a coworker took his own life in March of 2018. Skyler Gardner had worked in the Emergency Department for several years as a critical care tech lead. Dr. Balls said his death came as a shock to everyone.

“Skyler was loved by many and liked by all,” said Dr. Balls. “He had reached out to some people, but they didn’t know what to do.”

After his death, Skyler’s parents Blake and Wendy started a campaign on suicide prevention called “Love Yourself,” in hopes of getting people the help they need. As a part of the effort they made “Love Yourself” wristbands which ER staff wear and give out to patients in similar situations.

“We’re just overwhelmed to see them getting the word out, and remembering Skyler,” said Wendy. “I really hope telling his story will help others.

Intermountain Healthcare offers free counseling to all employees through the Employee Assistance Program. Dr. Balls said some caregivers may feel uncomfortable talking with a stranger not in their department. OASIS trains specific emergency room staff who caregivers can go to for help. It also trains those staff to look for signs of mental stress in others.

“We know people are silently struggling with issues both in and out of work, and we want them to know they don’t have to,” notes Dr. Balls.

Gary Brunson is the assistant nurse manager of the ED and one of the leaders of the OASIS program. He was good friends with Skyler and didn’t suspect something like this would happen.

Part of the Intermountain effort is acknowledging that caregivers see traumatic things as part of their job. The goal, Brunson notes, is for them to realize it’s okay to be bothered by it and ask for help in dealing with the impact it has on their mental health.

"We deal with some horrific things – we see things that burn images into our brains that we are just unable to ever really clear," said Brunson. "The stigma is that we are just supposed to deal with it."

Nurse Megan Frausto is also helping lead the effort of the new program. As someone who has struggled with mental health, she hopes telling her story will help others.

“The stigma surrounding mental health sadly still exists today,” said Frausto.“I was honored when they asked me to head up this program.”

The OASIS program will train nurses and physicians in suicide prevention and will select leaders and peer counselors.

Organizers hope talking about mental health will show others that it’s okay not to be okay. Dr. Balls said struggling through tough situations doesn’t have to be a part of working in the Emergency Department.

Intermountain Healthcare is a Utah-based not-for-profit system of 23 hospitals, 170 clinics, a Medical Group with some 2,300 employed physicians and advanced care practitioners, a health insurance company called SelectHealth, and other health services. Intermountain is widely recognized as a leader in transforming healthcare through evidence-based best practices, high quality, and sustainable costs. For more information about Intermountain, visit intermountainhealthcare.org.

Glen Beeby
Intermountain Healthcare
+1 206-948-4849
email us here


Source: EIN Presswire

Verve Dynamics Inc. and Maluti Green Med Succesfully Conclude the First Legal Transaction of Medical Cannabis in Africa

MASERU, LESOTHO, March 22, 2019 /EINPresswire.com/ — Verve Dynamics Incorporated (Pty) Ltd today announced that it has successfully concluded the first legal purchase of medicinal cannabis flowers in Africa for processing at it's Bela-Bela site.

"We are again part of being a first in Africa: says Richard Davies, CEO of Verve, "By supporting cannabis license holders like Maluti Green Med (MGM) we are continuing to ensure that the value add is kept local, and the people of Lesotho keep benefiting from this emerging market".

When asked for comment Dr Makwarela of MGM said: "As a licensed Drug Operator in Lesotho we are extremely pleased to be working with Verve, we have now proven our ability to get operational, sell product, and claim a first mover advantage in the local cannabis cultivation market".

Verve Dynamics intends opening its state of the art cultivation and processing facility by the end of April 2019. "Not only will we be purchasing high grade material from our local partners , but we will also be toll processing cannabis for them too: says Davies. "This service will include full spectrum extraction, isolation of individual actives, as well as packaging & drop shipping of their material through our secure network of aircraft and 3rd party bonded warehousing".

When asked for comment Mr Sam Matekane of MGC said: "We have had a lot of experience working with high value goods so we understand the complexities of such an undertaking. We are working closely with the Ministry of Health, Police officials, and international security companies to ensure that everything is transparent and follows international regulations when importing or exporting this valuable product".

-ENDS-

Richard Davies
Verve Dynamics Inc.
+27 21 851 1015
email us here


Source: EIN Presswire

Body Sensors Market 2019 Global Analysis, Share, Trend, Key Players, Opportunities & Forecast To 2023

PUNE, MAHARASHTRA, INDIA, March 22, 2019 /EINPresswire.com/ — Summary:

A new market study, titled “Discover Global Body Sensors Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

Introduction

Global Body Sensors Market

Body sensors and are small medical devices used for continuously monitoring temperature, pressure and other vital parameters of health. These sensors are incorporated with electrodes that sensor such parameters. Continuous monitoring helps a person to take preventive measures and avoid any further complications to his health.

The global Body Sensors market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Body Sensors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Body Sensors market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

 

@Get Free Sample Report at https://www.wiseguyreports.com/sample-request/3852710-global-body-sensors-market-research-report-2019

The following manufacturers are covered:

4B Braime

Allegro MicroSystems

Philips

Amsys GmbH

Althen GmbH

ASC

Balluff

Barksdale

Baumer

Segment by Regions

North America

Europe

China

Japan

Segment by Type

Motion sensors

Position sensors

Temperature sensor

Inertial sensors

Pressure sensor

Other

Segment by Application

Fitness

Blood pressure monitoring

Temperature monitoring

Heart rate monitoring

Weight monitoring

Other

@Get Detailed Report at https://www.wiseguyreports.com/reports/3852710-global-body-sensors-market-research-report-2019

Table of Contents

1 Body Sensors Market Overview

1.1 Product Overview and Scope of Body Sensors

1.2 Body Sensors Segment by Type

1.2.1 Global Body Sensors Production Growth Rate Comparison by Type (2014-2025)

1.2.2 Motion sensors

1.2.3 Position sensors

1.2.4 Temperature sensor

1.2.5 Inertial sensors

1.2.6 Pressure sensor

1.2.7 Other

1.3 Body Sensors Segment by Application

1.3.1 Body Sensors Consumption Comparison by Application (2014-2025)

1.3.2 Fitness

1.3.3 Blood pressure monitoring

1.3.4 Temperature monitoring

1.3.5 Heart rate monitoring

1.3.6 Weight monitoring

1.3.7 Other

1.4 Global Body Sensors Market by Region

1.4.1 Global Body Sensors Market Size Region

1.4.2 North America Status and Prospect (2014-2025)

1.4.3 Europe Status and Prospect (2014-2025)

1.4.4 China Status and Prospect (2014-2025)

1.4.5 Japan Status and Prospect (2014-2025)

1.5 Global Body Sensors Market Size

1.5.1 Global Body Sensors Revenue (2014-2025)

1.5.2 Global Body Sensors Production (2014-2025)

2 Global Body Sensors Market Competition by Manufacturers

2.1 Global Body Sensors Production Market Share by Manufacturers (2014-2019)

2.2 Global Body Sensors Revenue Share by Manufacturers (2014-2019)

2.3 Global Body Sensors Average Price by Manufacturers (2014-2019)

2.4 Manufacturers Body Sensors Production Sites, Area Served, Product Types

2.5 Body Sensors Market Competitive Situation and Trends

2.5.1 Body Sensors Market Concentration Rate

2.5.2 Body Sensors Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

……………

11 Global Body Sensors Market Forecast

11.1 Global Body Sensors Production, Revenue Forecast

11.1.1 Global Body Sensors Production Growth Rate Forecast (2019-2025)

11.1.2 Global Body Sensors Revenue and Growth Rate Forecast (2019-2025)

11.1.3 Global Body Sensors Price and Trend Forecast (2019-2025)

11.2 Global Body Sensors Production Forecast by Regions (2019-2025)

11.2.1 North America Body Sensors Production, Revenue Forecast (2019-2025)

11.2.2 Europe Body Sensors Production, Revenue Forecast (2019-2025)

11.2.3 China Body Sensors Production, Revenue Forecast (2019-2025)

11.2.4 Japan Body Sensors Production, Revenue Forecast (2019-2025)

11.3 Global Body Sensors Consumption Forecast by Regions (2019-2025)

11.3.1 North America Body Sensors Consumption Forecast (2019-2025)

11.3.2 Europe Body Sensors Consumption Forecast (2019-2025)

11.3.3 China Body Sensors Consumption Forecast (2019-2025)

11.3.4 Japan Body Sensors Consumption Forecast (2019-2025)

11.4 Global Body Sensors Production, Revenue and Price Forecast by Type (2019-2025)

11.5 Global Body Sensors Consumption Forecast by Application (2019-2025)

…………..

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Author List

13.4 Disclaimer

List of Tables and Figures

Figure Picture of Body Sensors

Table Global Body Sensors Production (K Units) Growth Rate Comparison by Types (2014-2025)

Figure Global Body Sensors Production Market Share by Types in 2018

Figure Motion sensors Product Picture

Table Motion sensors Major Manufacturers

Figure Position sensors Product Picture

Table Position sensors Major Manufacturers

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Blood Pressure Test Market 2019 Global Analysis, Share, Trend, Key Players, Opportunities & Forecast To 2023

PUNE, MAHARASHTRA, INDIA, March 22, 2019 /EINPresswire.com/ — Summary:

A new market study, titled “Discover Global Blood Pressure Test Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

Introduction

Global Blood Pressure Test Market

Automated Home Blood Pressure Monitors employ oscillometric measurements and electronic calculations rather than auscultation. They may use automatic inflation, but both types are electronic, easy to operate without training, and can be used in noisy environments.

The global Blood Pressure Test market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Blood Pressure Test volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blood Pressure Test market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

 

@Get Free Sample Report at https://www.wiseguyreports.com/sample-request/3852707-global-blood-pressure-test-market-research-report-2019

The following manufacturers are covered:

OMRON

A&D

Microlife

NISSEI

Panasonic

Welch Allyn

Yuwell

Beurer

Citizen

Andon

Rossmax

Bosch + Sohn

Homedics

Kingyield

Sejoy

Segment by Regions

North America

Europe

China

Japan

Segment by Type

Upper Arm

Wrist

Other

Segment by Application

Offline sales

Online sales

 

@Get Detailed Report at https://www.wiseguyreports.com/reports/3852707-global-blood-pressure-test-market-research-report-2019

Table of Contents

1 Blood Pressure Test Market Overview

1.1 Product Overview and Scope of Blood Pressure Test

1.2 Blood Pressure Test Segment by Type

1.2.1 Global Blood Pressure Test Production Growth Rate Comparison by Type (2014-2025)

1.2.2 Upper Arm

1.2.3 Wrist

1.2.4 Other

1.3 Blood Pressure Test Segment by Application

1.3.1 Blood Pressure Test Consumption Comparison by Application (2014-2025)

1.3.2 Offline sales

1.3.3 Online sales

1.4 Global Blood Pressure Test Market by Region

1.4.1 Global Blood Pressure Test Market Size Region

1.4.2 North America Status and Prospect (2014-2025)

1.4.3 Europe Status and Prospect (2014-2025)

1.4.4 China Status and Prospect (2014-2025)

1.4.5 Japan Status and Prospect (2014-2025)

1.5 Global Blood Pressure Test Market Size

1.5.1 Global Blood Pressure Test Revenue (2014-2025)

1.5.2 Global Blood Pressure Test Production (2014-2025)

2 Global Blood Pressure Test Market Competition by Manufacturers

2.1 Global Blood Pressure Test Production Market Share by Manufacturers (2014-2019)

2.2 Global Blood Pressure Test Revenue Share by Manufacturers (2014-2019)

2.3 Global Blood Pressure Test Average Price by Manufacturers (2014-2019)

2.4 Manufacturers Blood Pressure Test Production Sites, Area Served, Product Types

2.5 Blood Pressure Test Market Competitive Situation and Trends

2.5.1 Blood Pressure Test Market Concentration Rate

2.5.2 Blood Pressure Test Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

…………..

11 Global Blood Pressure Test Market Forecast

11.1 Global Blood Pressure Test Production, Revenue Forecast

11.1.1 Global Blood Pressure Test Production Growth Rate Forecast (2019-2025)

11.1.2 Global Blood Pressure Test Revenue and Growth Rate Forecast (2019-2025)

11.1.3 Global Blood Pressure Test Price and Trend Forecast (2019-2025)

11.2 Global Blood Pressure Test Production Forecast by Regions (2019-2025)

11.2.1 North America Blood Pressure Test Production, Revenue Forecast (2019-2025)

11.2.2 Europe Blood Pressure Test Production, Revenue Forecast (2019-2025)

11.2.3 China Blood Pressure Test Production, Revenue Forecast (2019-2025)

11.2.4 Japan Blood Pressure Test Production, Revenue Forecast (2019-2025)

11.3 Global Blood Pressure Test Consumption Forecast by Regions (2019-2025)

11.3.1 North America Blood Pressure Test Consumption Forecast (2019-2025)

11.3.2 Europe Blood Pressure Test Consumption Forecast (2019-2025)

11.3.3 China Blood Pressure Test Consumption Forecast (2019-2025)

11.3.4 Japan Blood Pressure Test Consumption Forecast (2019-2025)

11.4 Global Blood Pressure Test Production, Revenue and Price Forecast by Type (2019-2025)

11.5 Global Blood Pressure Test Consumption Forecast by Application (2019-2025)

…………..

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Author List

13.4 Disclaimer

List of Tables and Figures

Figure Picture of Blood Pressure Test

Table Global Blood Pressure Test Production (K Units) Growth Rate Comparison by Types (2014-2025)

Figure Global Blood Pressure Test Production Market Share by Types in 2018

Figure Upper Arm Product Picture

Table Upper Arm Major Manufacturers

Figure Wrist Product Picture

Table Wrist Major Manufacturers

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Global Antidiabetics Market Analysis, Growth, Global Trends, Opportunity & Forecast 2019 to 2025

Wise.Guy12

Wise.Guy.

WiseGuyRerports.com Presents “Global Antidiabetics Market Size, Status and Forecast 2019-2025” New Document to its Studies Database

PUNE, INDIA, March 22, 2019 /EINPresswire.com/ —

In 2018, the global Antidiabetics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global Antidiabetics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antidiabetics development in United States, Europe and China.

The key players covered in this study 
Pfizer 
AstraZeneca 
Johnson & Johnson 
GlaxoSmithKline 
Merck & Co 
Eli Lilly 
Sanofi 
Takeda Pharmaceuticals 
Novo Nordisk 
Servier Laboratories 
Boehringer Ingelheim 
Bristol-Myers Squibb 
MannKind 
BIOTON 
Salix Pharmaceuticals

 

 Request For Sample Report @ https://www.wiseguyreports.com/sample-request/3715120-global-antidiabetics-market-size-status-and-forecast-2019-2025                      

                                     

Market segment by Type, the product can be split into 
Rapid Acting 
Long Acting 
Short Acting 
Other

Market segment by Application, split into 
Hospitals 
Clinics 
Other

Market segment by Regions/Countries, this report covers 
United States 
Europe 
China 
Japan 
Southeast Asia 
India 
Central & South America

The study objectives of this report are: 
To analyze global Antidiabetics status, future forecast, growth opportunity, key market and key players. 
To present the Antidiabetics development in United States, Europe and China. 
To strategically profile the key players and comprehensively analyze their development plan and strategies. 
To define, describe and forecast the market by product type, market and key regions.

 

Complete Report Details @ https://www.wiseguyreports.com/reports/3715120-global-antidiabetics-market-size-status-and-forecast-2019-2025              

Table Of Contents:      

1 Report Overview 
1.1 Study Scope 
1.2 Key Market Segments 
1.3 Players Covered 
1.4 Market Analysis by Type 
1.4.1 Global Antidiabetics Market Size Growth Rate by Type (2014-2025) 
1.4.2 Rapid Acting 
1.4.3 Long Acting 
1.4.4 Short Acting 
1.4.5 Other 
1.5 Market by Application 
1.5.1 Global Antidiabetics Market Share by Application (2014-2025) 
1.5.2 Hospitals 
1.5.3 Clinics 
1.5.4 Other 
1.6 Study Objectives 
1.7 Years Considered

2 Global Growth Trends 
2.1 Antidiabetics Market Size 
2.2 Antidiabetics Growth Trends by Regions 
2.2.1 Antidiabetics Market Size by Regions (2014-2025) 
2.2.2 Antidiabetics Market Share by Regions (2014-2019) 
2.3 Industry Trends 
2.3.1 Market Top Trends 
2.3.2 Market Drivers 
2.3.3 Market Opportunities

….

12 International Players Profiles 
12.1 Pfizer 
12.1.1 Pfizer Company Details 
12.1.2 Company Description and Business Overview 
12.1.3 Antidiabetics Introduction 
12.1.4 Pfizer Revenue in Antidiabetics Business (2014-2019) 
12.1.5 Pfizer Recent Development 
12.2 AstraZeneca 
12.2.1 AstraZeneca Company Details 
12.2.2 Company Description and Business Overview 
12.2.3 Antidiabetics Introduction 
12.2.4 AstraZeneca Revenue in Antidiabetics Business (2014-2019) 
12.2.5 AstraZeneca Recent Development 
12.3 Johnson & Johnson 
12.3.1 Johnson & Johnson Company Details 
12.3.2 Company Description and Business Overview 
12.3.3 Antidiabetics Introduction 
12.3.4 Johnson & Johnson Revenue in Antidiabetics Business (2014-2019) 
12.3.5 Johnson & Johnson Recent Development 
12.4 GlaxoSmithKline 
12.4.1 GlaxoSmithKline Company Details 
12.4.2 Company Description and Business Overview 
12.4.3 Antidiabetics Introduction 
12.4.4 GlaxoSmithKline Revenue in Antidiabetics Business (2014-2019) 
12.4.5 GlaxoSmithKline Recent Development 
12.5 Merck & Co 
12.5.1 Merck & Co Company Details 
12.5.2 Company Description and Business Overview 
12.5.3 Antidiabetics Introduction 
12.5.4 Merck & Co Revenue in Antidiabetics Business (2014-2019) 
12.5.5 Merck & Co Recent Development 

 Continued…….                                                      

 

CONTACT US:

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
646 845 9349 / +44 208 133 9349
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Spine Surgery Products Market 2019, Global Industry Analysis, Size, Share, Growth, Trends and Forecast – 2024

WiseGuyReports.com adds “Spine Surgery Products Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024”

PUNE, MAHARASHTRA, INDIA, March 22, 2019 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Spine Surgery Products Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database.

This report provides in depth study of “Spine Surgery Products Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Spine Surgery Products Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Spinal fusion products are used in spinal fusion surgery. The products are involved in removing the damaged disc and replacing it with any fusion products. Non-fusion products are used during spine surgery, which are implanted to treat spine conditions. This also allows the patient to retain its movement and flexibility. The non-fusion products are becoming the treatment of choice, especially for the younger, more active patient. Increase in number of spine surgeries, rise in use of bone grafts and bone morphogenetic proteins in spinal fusion surgery, growing number of spinal surgeries using electrical stimulation devices such as inductive coupling devices, captive coupling devices and other implants drives the market growth rate by 2025.

Global Spine Surgery Products market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Medtronic
DePuy Synthes
NuVasive
Stryker
Globus Medical
Zimmer Biomet
K2M
Orthofix International
Alphatec
RTI Surgical
B. Braun
Xtant Medical
Wright Medical
SeaSpine
Amedica
Invibio

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3463011-2015-2023-world-spine-surgery-products-market-research

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)

By Type
Spinal Fusion Products
Non-fusion Products

By End-User / Application
Open Surgery
Minimally Invasive Surgery

At any Query @ https://www.wiseguyreports.com/enquiry/3463011-2015-2023-world-spine-surgery-products-market-research

Major Key Points in Table of Content

1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs

5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa

……

12 Key Manufacturers
12.1 Medtronic
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 DePuy Synthes
12.2.1 Company Overview
12.2.2 Product and End-User / Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 NuVasive
12.3.1 Company Overview
12.3.2 Product and End-User / Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 Stryker
12.4.1 Company Overview
12.4.2 Product and End-User / Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 Globus Medical
12.5.1 Company Overview
12.5.2 Product and End-User / Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 Zimmer Biomet
12.12.1 Company Overview
12.12.2 Product and End-User / Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 K2M
12.7.1 Company Overview
12.7.2 Product and End-User / Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 Orthofix International
12.8.1 Company Overview
12.8.2 Product and End-User / Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 Alphatec
12.9.1 Company Overview
12.9.2 Product and End-User / Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 RTI Surgical
12.10.1 Company Overview
12.10.2 Product and End-User / Application
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.11 B. Braun
12.12 Xtant Medical
12.13 Wright Medical
12.14 SeaSpine
12.15 Amedica
12.16 Invibio

Buy NOW @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3463011

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Transvaginal Endoscopy Market 2019, Global Industry Analysis, Size, Share, Growth, Trends and Forecast – 2024

WiseGuyReports.com adds “Transvaginal Endoscopy Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024”

PUNE, MAHARASHTRA, INDIA, March 22, 2019 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Transvaginal Endoscopy Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database.

This report provides in depth study of “Transvaginal Endoscopy Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Transvaginal Endoscopy Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Global Transvaginal Endoscopy market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Karl Storz
Astra
Boston Scientific
Ethicon Inc.
Tristel
Visap
Centrel
Endoservice Optical Instruments
Emos Technology
Blazejewski MEDI-TECH
Alltion
AIIM

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3463091-2015-2023-world-transvaginal-endoscopy-market-research-report

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)

By Type
Straight
Bent

By End-User / Application
Hosptial
Clinic
Others

At any Query @ https://www.wiseguyreports.com/enquiry/3463091-2015-2023-world-transvaginal-endoscopy-market-research-report

Major Key Points in Table of Content

1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs

5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa

……

12 Key Manufacturers
12.1 Karl Storz
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Astra
12.2.1 Company Overview
12.2.2 Product and End-User / Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 Boston Scientific
12.3.1 Company Overview
12.3.2 Product and End-User / Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 Ethicon Inc.
12.4.1 Company Overview
12.4.2 Product and End-User / Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 Tristel
12.5.1 Company Overview
12.5.2 Product and End-User / Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 Visap
12.12.1 Company Overview
12.12.2 Product and End-User / Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 Centrel
12.7.1 Company Overview
12.7.2 Product and End-User / Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 Endoservice Optical Instruments
12.8.1 Company Overview
12.8.2 Product and End-User / Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 Emos Technology
12.9.1 Company Overview
12.9.2 Product and End-User / Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 Blazejewski MEDI-TECH
12.10.1 Company Overview
12.10.2 Product and End-User / Application
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.11 Alltion
12.12 AIIM

Buy NOW @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3463091

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire